BABA
Alibaba Group Holding Limited
BABA has the edge over DBI overall, supported by stronger valuation and lower modeled downside.
DBI
Designer Brands Inc.
DBI offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
DBI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Stable |
DBI's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA has the edge over DBI in the historical PE scenario, which offers more potential upside but is not a forecast.
DBI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.9x | $1.47 | -77% |
| Fair | 7x | $2.10 | -67% |
| Forward | 12x | $6.43 | — |
| Current | 21x | $6.43 | — |
| Expensive | 25x | $7.44 | +16% |
Historical ranges are pointers, not guarantees.
DBI's PE is in its expensive range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its fair range.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over DBI on the outlook, with more favorable revenue and profitability expectations.
DBI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect DBI's earnings to grow, with its revenue and profitability holding steady.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
DBI has the stronger earnings trend. Trailing diluted EPS is down 52% for BABA versus DBI up 1,400%.
DBI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.55 | +82% |
| Q4 2024 | $0.05 | -97% |
| Q3 2024 | -$0.02 | -101% |
| Q2 2024 | $0.30 | -86% |
| Q1 2024 | $0.46 | -80% |
| Q4 2023 | $1.55 | -14% |
| Q3 2023 | $2.03 | -7.3% |
| Q2 2023 | $2.09 | -1.4% |
| Q1 2023 | $2.26 | +13% |
DBI has returned to profit: it earned $0.30 per share over the past year, after losing money the year before.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over DBI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
DBI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $730.6M | -1.2% |
| Q2 2026 | $696.4M | +1.4% |
| Q1 2026 | $713.6M | 0% |
| Q4 2025 | $752.4M | -3.2% |
| Q3 2025 | $739.8M | -4.2% |
| Q2 2025 | $686.9M | -8% |
| Q1 2025 | $713.6M | -5.4% |
| Q4 2024 | $777.2M | -1.2% |
DBI's revenue fell from its 2019 peak and has held roughly level since: $731M last quarter, down 1.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.5% | +3.9 points |
| Q2 2026 | 2.7% | +3.8 points |
| Q1 2026 | -2% | +1.6 points |
| Q4 2025 | 5.7% | +2.7 points |
| Q3 2025 | 3.6% | -0.1 points |
| Q2 2025 | -1.1% | -2.3 points |
| Q1 2025 | -3.6% | +1.1 points |
| Q4 2024 | 2.9% | -0.6 points |
DBI has the edge over BABA on profitability, with a higher operating margin.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
DBI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $57.9M | +386% |
| Q2 2026 | -$31.9M | -$4.3M |
| Q1 2026 | $36.4M | -37% |
| Q4 2025 | $57.5M | +$76.7M |
| Q3 2025 | $11.9M | -57% |
| Q2 2025 | -$27.6M | +$8M |
| Q1 2025 | $58.1M | +$110.9M |
| Q4 2024 | -$19.2M | -138% |
DBI has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has the edge over DBI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
DBI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +54K shares |
| 1 year | +13% | +6.2M shares |
| 3 years | -17% | -11.1M shares |
| 5 years | -27% | -21M shares |
| Available history | -23% | -17M shares |
DBI has 56M diluted shares, up 13% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $50.6M |
| Q1 2024 | $54,000 |
| Q4 2023 | $79.7M |
| Q3 2023 | $22.4M |
| Q2 2023 | — |
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA has the edge over DBI on leverage, with a lower net debt burden relative to earnings.
DBI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.3x | Moderate |
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.5x | Elevated |
| Q4 2025 | 4.3x | High |
| Q3 2025 | 6.0x | High |
| Q2 2025 | 5.8x | High |
| Q1 2025 | 4.5x | High |
| Q4 2024 | 5.4x | High |
DBI's net debt is about 2.3 years of its operating earnings (EBITDA), down from 6.0 years a year ago.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
DBI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.6 | Neutral |
| Stochastic | 71.1 | Neutral |
DBI's weekly RSI is 53 (neutral) and its Stochastic is 71 (neutral).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA has the edge over DBI on valuation relative to its sector.
DBI PE vs Consumer Cyclical Sector
| Metric | DBI | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 75 | 47 | 28 pts above |
DBI is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
DBI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.25 | 2.9% above |
| 20 week MA | $5.96 | 7.9% above |
| 50 week MA | $6.55 | 1.8% below |
| 100 week MA | $5.18 | 24% above |
| 200 week MA | $7.00 | 8.1% below |
DBI has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
DBI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.6 | $7.14 | -54% |
| 2021 | $7.14 | $14.5 | +103% |
| 2022 | $14.5 | $9.82 | -32% |
| 2023 | $9.82 | $8.85 | -9.9% |
| 2024 | $8.85 | $5.40 | -39% |
| 2025 | $5.40 | $7.78 | +44% |
| 2026 YTD | $7.78 | $6.43 | -17% |
DBI has the edge over BABA on returns for 2026, with the stronger performance.